Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,844 | 38,063 | 23,058 | 25,458 | 16,507 |
| Marketable Securities | 83,510 | 77,684 | 40,433 | 53,802 | 46,365 |
| Receivables | 8,595 | 6,404 | 7,446 | 8,452 | 13,433 |
| Inventories | 17,878 | 19,694 | 23,440 | 25,930 | 23,065 |
| TOTAL | $131,659 | $143,873 | $96,412 | $115,699 | $101,619 |
| Non-Current Assets | |||||
| PPE Net | 34,073 | 34,490 | 36,103 | 36,704 | 37,920 |
| Other Non-Current Assets | 4,543 | 4,543 | 4,543 | 4,546 | 4,545 |
| TOTAL | $38,616 | $39,033 | $40,646 | $41,250 | $42,465 |
| Total Assets | $170,275 | $182,906 | $137,058 | $156,949 | $144,084 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,736 | 5,966 | 4,169 | 8,567 | 9,093 |
| Accrued Expenses | 12,823 | 9,298 | 10,935 | 10,243 | 12,618 |
| Other current liabilities | 788 | 645 | 744 | 145 | 605 |
| TOTAL | $26,884 | $21,649 | $22,264 | $24,948 | $28,635 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,659 | 14,384 | 14,121 | 13,872 | 13,635 |
| Deferred Revenues | 6,537 | 5,740 | 6,416 | 5,993 | 6,319 |
| Other Non-Current Liabilities | 16 | 13,977 | 14,146 | 14,297 | 14,636 |
| TOTAL | $29,330 | $29,377 | $29,320 | $29,263 | $29,346 |
| Total Liabilities | $56,214 | $51,026 | $51,584 | $54,211 | $57,981 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 150,960 | 148,902 | 131,942 | 131,877 | 130,694 |
| Common Shares | 150 | 149 | 132 | 132 | 116 |
| Retained earnings | -982,106 | -951,307 | -926,263 | -903,723 | -879,733 |
| Other shareholders' equity | -36 | -24 | -16 | -38 | -32 |
| TOTAL | $114,061 | $131,880 | $85,474 | $102,738 | $86,103 |
| Total Liabilities And Equity | $170,275 | $182,906 | $137,058 | $156,949 | $144,084 |